drugset / Trial / NCT02195154

18F-DTBZ PET and Multi-modal MRI in the Patients With Vascular Parkinsonism

NCT02195154

NaSingle-groupOpen-labelDiagnostic

Summary

Forty patients with clinically diagnosed VP and 20 healthy subjects will be enrolled in the study. Each evaluable subject involved in this study must fulfill all the inclusion and exclusion criteria and each subject will have 3 visits in the study, as one screening visit, one imaging visit, and one safety evaluation visit.

Timeline

Start
2013-11
Primary completion
2017-07-31
Completion
2017-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject 18F-DTBZ Diagnostic / imaging agent 370 mbq Intravenous

Indications